Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Aytu Biopharma (AYTU) Shares Outstanding (Diluted Average) (2020 - 2026)

Aytu Biopharma has reported Shares Outstanding (Diluted Average) over the past 6 years, most recently at $10.0 million for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 14.27% to $10.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.0 million through Dec 2025, up 14.27% year-over-year, with the annual reading at $3.3 million for FY2023, 127.22% up from the prior year.
  • Shares Outstanding (Diluted Average) was $10.0 million for Q4 2025 at Aytu Biopharma, down from $19.5 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $19.5 million in Q3 2025 and troughed at $1.3 million in Q3 2021.
  • The 5-year median for Shares Outstanding (Diluted Average) is $5.5 million (2023), against an average of $6.3 million.
  • Year-over-year, Shares Outstanding (Diluted Average) crashed 91.22% in 2022 and then surged 151.05% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $1.3 million in 2021, then skyrocketed by 135.52% to $3.1 million in 2022, then surged by 77.4% to $5.5 million in 2023, then soared by 59.18% to $8.8 million in 2024, then increased by 14.27% to $10.0 million in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Shares Outstanding (Diluted Average) are $10.0 million (Q4 2025), $19.5 million (Q3 2025), and $8.2 million (Q1 2025).